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ABSTRACT
Introduction. Implant related infection is a serious complication and difficult to manage. Antimicrobial coating on 
implant surface is expected to prevent infection. Gentamicin is a broad-spectrum antibiotic that has been widely 
applied locally. Chitosan is a biopolymer that has bio adhesive properties and can serve as a drug carrier.
Materials and methods. This is an in vitro experimental study to assess the effectiveness of gentamicin-loaded 
chitosan-coated Steinmann pin on the growth of Staphylococcus epidermidis. Seven test groups were made, consist 
of five different concentration of gentamicin-loaded chitosan, chitosan coating only, and control without coating. 
Evaluation is done by assessing turbidity (qualitative measurement) and colony forming unit count (quantitative 
measurement). The experiment was repeated three times.
Results. In the evaluation of turbidity level and colony forming unit count, we obtained gradual decline in line with 
the concentration. Gentamicin concentration of 4µg inhibits the growth of Staphylococcus epidermidis. 
Conclusions. This study found that gentamicin-loaded chitosan-coated Steinmann pin could inhibit 
Staphylococcus epidermidis growth in vitro. The most optimum concentration of gentamicin was 4 µg. 
Keywords: Implant related infection, implant coating, Steinmann pin, chitosan, gentamicin, Staphylococcus 
epidermidis
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Efektivitas Pelapisan Steinmann Pin dengan Gentamicin dan Chitosan terhadap 
Pertumbuhan Staphylococcus epidermidis
ABSTRAK
Pendahuluan. Infeksi pada penggunaan implan merupakan komplikasi serius yang sulit untuk ditangani. 
Pendekatan dengan pemakaian lapisan antimikroba pada permukaan implan diharapkan dapat mencegah 
terjadinya infeksi. Gentamicin merupakan antibiotik berspektrum luas yang telah banyak diaplikasikan 
secara lokal. Chitosan merupakan polimer yang memiliki sifat bioadhesif dan dapat berfungsi sebagai agen 
pembawa obat.
Bahan dan cara kerja. Penelitian ini merupakan penelitian eksperimental in vitro untuk menilai efektivitas 
pelapisan Steinmann pin dengan gentamicin dan chitosan terhadap pertumbuhan Staphyloccus epidermidis. 
Penelitian melibatkan tujuh kelompok uji yang terdiri dari kontrol, pelapis chitosan, dan lima kelompok 
gentamisin dengan konsentrasi bertingkat. Evaluasi dilakukan dengan menilai kekeruhan dan penghitungan 
jumlah koloni. Percobaan dilakukan tiga kali pengulangan.
Hasil. Pada evaluasi tingkat kekeruhan dan penghitungan jumlah koloni kuman, didapatkan penurunan 
secara gradual pada tiga kali percobaan sesuai tingkat konsentrasi.  Konsentrasi gentamicin 4 ug mampu 
menghambat pertumbuhan Staphylococcus epidermidis. Secara statistik didapatkan perbedaan secara 
bermakna antara kelompok perlakuan dengan kontrol. (p = 0,038) Kelompok gentamicin 4µg berbeda 
secara bermakna dengan kelompok kontrol dan kelompok chitosan. 
Simpulan. Steinmann pin yang dilapisi dengan chitosan dan antibiotik menghambat pertumbuhan 
Staphylococcus epidermidis secara in vitro. Konsentrasi optimum tercapat pada kadar gentamicin 4 µg. 
Kata kunci: implant related infection, implant coating, Steinmann pin, chitosan, gentamicin, S. epidermidis
Introduction
Musculoskeletal infection is a complication that often 
accompanies orthopedic surgery.1 The incidence of 
infection reaches 5% in fracture fixation with appliance 
and installation and 2% in fixation with prosthesis. About 
1.8 billion dollars each year is required for handling the 
implant-related infection’s cases. Such infections cause 
morbidity to the patient in question and pose a huge burden 
on the health care system.2 Pathogenesis of infection 
is associated with the presence of microorganism in 
biofilms. Biofilms are collections of cells and cellular 
products and form a layer attached to solid surface or 
substrate surface. Based on the uniqueness of this bone 
infection, the best management is prevention. 
The use of antimicrobial coatings on the surface 
properties of biodegradable implants is the current 
strategy developed in order to prevent the occurrence 
of infection in orthopedic implant use. The use of 
antimicrobial coating is expected to prevent the 
attachment of bacteria on the surface of the implant so 
it does not form biofilms.3 Various materials and types 
of antibiotics have been tested as an implant coating. 
Chitosan is a biopolymer considered to inhibit the growth 
of bacteria on implants.4
Gentamicin is a prototype of aminoglycoside with a 
broad spectrum. The main indication of the antibiotic is 
a general severe infection with gram-negative bacteria. 
Gentamicin has a bactericidal function. Glycoside 
antibiotics inhibit bacterial protein biosynthesis. The 
accumulation of antibiotic on the bacterial ribosome 
cause misreading in translation, resulting in the formation 
of incorrect enzyme protein and structure of one protein, 
causing an irreversible cell damage.5 
The purpose of this study was to determine the 
antibacterial power of coating the stainless steel implant 
using a mixed solution of chitosan and gentamicin.
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Materials and methods
This was an experimental study. Staphylococcus 
epidermidis bacteria used in this study was obtained 
from microbiology laboratory of Faculty of Medicine, 
University of Gadjah Mada. Gentamicin in five different 
concentration levels was used as independent variable 
in this study. The evaluation covered turbidity level of 
isolates of Staphylococcus epidermidis and number of 
colony forming units (CFU) observed with naked eye. 
Preparation of gentamicin-loaded chitosan. The 
concentration of chitosan used in this study was 3% and 
2% in 1% H3COOH solution.  To create a 3% and 2% 
solution of chitosan, a total of 75 and 50 µg of chitosan 
powder was dissolved into 250 ml of solvent H3COOH 
1% and then stirred using a magnetic Stirrer for one 
hour to become homogeneous.  Gentamicin in 5 levels 
of concentration (4, 2, 1, 0.5, 0.25 µg) was mixed with 
the solution. Concentration of 4 µg is determined by 
maximum inhibitory concentration and validation tests 
performed previously, where at 4 µg concentration, no 
colony growth was found. 
Pin coating procedure. Pin coating was done in two 
stages. The first stage used 3% chitosan 3and after it had 
been dried at room temperature for 24 hours, the second 
stages followed by using 2% chitosan. 
Preparation of Staphylococcus epidermidis. 
Staphylococcus epidermidis was cultured in Trypticase 
Soy Broth (TSB) media and cultured in Muller Hinton 
agar of 100μl. They were incubated at 37 ºC for 24 
hours. Several colonies were taken from the culture and 
suspended in 10 ml 0.9% NaCl to obtain turbidity equal 
to Mc. Farland standard solution. 
Bacterial concentration obtained was 108 CFU/ml. 
Concentration was then used as a standard in doing this 
research. 
Incubation of Staphylococcus epidermidis to 
Steinmann pin. Steinmann pin was introduced into a tube 
containing 200 ml Staphylococcus epidermidis solution. 
They were incubated for twenty four hours at 37 oC. The 
procedure was conducted in triplo in different time.
Measurement of outcome. The evaluations of the 
antimicrobial effect against Staphylococcus epidermidis 
and gentamicin chitosan coating were done qualitatively 
and quantitatively. Qualitative test was done by 
comparing turbidity level of the treated group with a 
visual control. As a control, the same bacterial isolates 
are used regardless of the treatment (positive control) as 
a benchmark of turbidity level. Assessment of turbidity 
level was done visually in a bright room and with a clean 
and homogeneous screen. Blinding examination was 
done by two persons to reduce bias and subjectivity. 
Quantitative evaluation to calculate CFU was carried 
out by growing isolates in Muller Hinton medium that 
was incubated for 24 hours at temperature of 37 ˚C. A 
total of 0.1 ml isolate of gentamicin at each level and 
concentration of chitosan were extracted using a pipette 
and flattened on the surface of agar media. Each media 
was labeled with corresponding gentamicin level and 
chitosan’s concentration. Evaluation was done by 
counting the number of colony that was visually formed. 
Counting was performed by two blinded examiner 
to reduce bias and subjectivity. Data obtained from 
the research results were statistically analyzed using 
Kruskal-Wallis test and Mann-Whitney test. Statistical 
analysis was performed using IBM SPSS version 17.
Results
Based on observations, a difference in turbidity level was 
found between isolates in the negative control with pin 
treated using chitosan coating mixture and gentamicin. 
Optimum results were obtained in pin coated with 2 and 4 
µg gentamicin. Pin coated with chitosan alone also results 
in relatively lower turbidity compared with uncoated 
pin and pin coated with 0.25, 0.5, and 1 µg gentamicin. 
There was a decreasing gradation of turbidity starting 
from the noncoated pin and pin coated with gentamicin 
level ranging from 0.25 to 4 µg. It was found that the 
higher the level of gentamicin, the lower the turbidity 
level. The tube was appeared clear on the pin coated with 
gentamicin 0.25 µg on the first and third experiment and 
also on the pin with chitosan alone, while in the second 
experiment, the tube appeared clear at a concentration 
of 0.5 µg gentamicin and the tube coated with chitosan 
alone was appeared not clear. 
We found decreasing gradation level on the growth 
of isolates Staphylococcus epidermidis in line with the 
decreasing level of gentamicin, with less or no growth 
at higher level of gentamicin. In the first experiment, 
the bacteria completely did not grow at concentrations 
of gentamicin 4 µg. At concentrations below 4 µg, 
gentamicin was seen only able to inhibit the growth of 
Staphylococcus epidermidis.
In the group given only chitosan without gentamicin, the 
growth of Staphylococcus epidermidis isolates were also 
relatively low compared to the control and quantity was 
lower than the group with pin coated with gentamicin 0.5 µg. 
The first, second, and third experiments showed different 
results at the same level of concentration. Nevertheless, 
it showed significant gradations of colony growth rate in 
line to the concentration of gentamicin in all experiments. 
Based on the Kruskal-Wallis test, the number of 
41
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colonies in each experimental group differed significantly. 
(p =  0.038)  Mann-Whitney test resulted in significant 
mean difference between the control group with groups 
of 2 µg and 4 µg gentamicin. Comparing only groups 
with gentamicin-loaded chitosan, there were significant 
differences only in the group of gentamicin 4 µg. Group 
treated with gentamicin 4 µg differed significantly with 
all test groups except with gentamicin 2 µg and 1 µg. 
Discussions
Systemic antibiotic was given before orthopedic surgery 
to prevent infection in the use of implants. Due to 
disturbances in bone structure and local vascularization, 
adequate doses of antibiotics cannot be achieved at 
the site of implant. Implant-bone surface are prone to 
infection, therefore the use of local antibiotics is very 
reasonable. Side effects of systemic antibiotics can be 
avoided and the dose of higher local antibiotic can be 
given without risk of systemic toxicity.6
The use of gentamicin as a local antibiotic which 
is shown to be effective in a variety of orthopedic 
surgery, with bactericidal properties, broad spectrum 
and stable to high temperatures has become the basis 
for selection of gentamicin in this study.3 Gentamicin is 
stable to heat which may arise from the drilling or screw 
insertion. Furthermore, the pattern of infection-related 
bacteria in Sardjito General Hospital was mostly class 
of  Staphylococcus.7 Although most of the activity of 
gentamicin is gram-negative bacteria, it also works on 
gram-positive bacteria such as Staphylococcus. 
We found barriers to the growth of bacterial isolates 
of Staphylococcus epidermidis after treated with 
gentamicin-coated pin, indicated by the decrease in 
turbidity and number of CFU. Coating with chitosan 
and gentamicin concentration of 2 µg and 4 µg gives 
real effect as anti-bacterial than the other. These results 
were supported by statistical analysis which shows real 
differences between treatment groups. The effectiveness 
of gentamicin and chitosan as a coating implant are 
consistent with the experiment of Greene in 2007 which 
showed that gentamicin would start with real decays in 
72-96 hours and to eliminate Staphylococcus epidermidis 
in the incubation period of 16-20 hours. 
Chitosan as a cation have adhesive properties. It is 
biocompatible and not toxic to tissue. In this study, it was 
shown that chitosan itself had antibacterial properties in 
both qualitative and quantitative test. On the qualitative 
tests, it appeared that group of isolates given pin coated 
only with chitosan demonstrated to inhibit the growth of 
bacteria. Similarly, on the quantitative test, relatively low 
numbers of colony was found.
Antibacterial effects of chitosan itself was relatively 
strong, but at the time of mixing with gentamicin, the 
antibacterial effect of chitosan was decreasing as seen 
in the levels of 0.25 µg and 0.5 µg in all the repetitions 
both qualitatively and quantitatively. That happened 
because of the possibility of antagonistic effects between 
chitosan and gentamicin, for mechanical or because of 
other reasons that still requires further investigation.
 This study still has several shortcomings, including 
limited sample and using only one kind of antibiotic. 
Furthermore, measuring duration of gentamicin and 
chitosan coating stays on the pin was not done. This 
study implies local approach to the manipulation of 
surface of implant for treatment of infection may give 
effective results. However, further research about this 
should be done. 
Conclusions
This study found that gentamicin-loaded chitosan-coated 
Steinmann pin could inhibit Staphylococcus epidermidis 
growth in vitro. The most optimum concentration of 
gentamicin was 4 µg. 
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